We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

127 hedge funds and large institutions have $210M invested in Dynavax Technologies in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more call options, than puts

Call options by funds: $3.4M | Put options by funds: $1.75M

3% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 36

2.41% less ownership

Funds ownership: 83.35%80.93% (-2.4%)

7% less funds holding

Funds holding: 137127 (-10)

27% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 30

46% less capital invested

Capital invested by funds: $392M → $210M (-$182M)

Holders
127
Holders Change
-10
Holders Change %
-7.3%
% of All Funds
2.76%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
37
Reduced
36
Closed
30
Calls
$3.4M
Puts
$1.75M
Net Calls
+$1.65M
Net Calls Change
+$823K
Name Holding Trade Value Shares
Change
Change in
Stake
Commonwealth Equity Services
76
Commonwealth Equity Services
Massachusetts
$104K +$15.7K +2,710 +12%
RJA
77
Raymond James & Associates
Florida
$100K -$38.4K -6,626 -21%
State Board of Administration of Florida Retirement System
78
State Board of Administration of Florida Retirement System
Florida
$100K
PPA
79
Parametric Portfolio Associates
Washington
$91K -$3.55K -613 -3%
CIBC Private Wealth Group
80
CIBC Private Wealth Group
Georgia
$90K
Invesco
81
Invesco
Georgia
$85K -$4.2K -724 -3%
HHMI
82
Howard Hughes Medical Institute
Maryland
$85K
UBS Group
83
UBS Group
Switzerland
$82K -$152K -26,208 -56%
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
$81K
QT
85
Quantbot Technologies
New York
$81K +$119K +20,498 New
JP Morgan Chase
86
JP Morgan Chase
New York
$77K -$1.45M -249,566 -93%
ACM
87
AlphaCrest Capital Management
New York
$71K
ARTA
88
A.R.T. Advisors
New York
$70K -$724K -124,800 -88%
Creative Planning
89
Creative Planning
Kansas
$63K -$1.28M -220,000 -93%
Wolverine Trading
90
Wolverine Trading
Illinois
$61K -$288K -49,754 -76%
GCP
91
GSA Capital Partners
United Kingdom
$59K +$85.3K +14,705 New
M&T Bank
92
M&T Bank
New York
$54K +$18.1K +3,116 +29%
Legal & General Group
93
Legal & General Group
United Kingdom
$47K
AB
94
Amalgamated Bank
New York
$47K +$67.8K +11,691 New
PFGIA
95
Patriot Financial Group Insurance Agency
Massachusetts
$45K -$38.8K -6,700 -37%
Simplex Trading
96
Simplex Trading
Illinois
$43K -$210K -36,251 -77%
Royal Bank of Canada
97
Royal Bank of Canada
Ontario, Canada
$42K -$47.9K -8,269 -44%
WS
98
Wedbush Securities
California
$42K +$60.9K +10,500 New
VF
99
Virtu Financial
New York
$41K +$59.1K +10,193 New
RE
100
RBC Europe
United Kingdom
$39.5K

DVAX Hedge Fund Activity: Q2 2019 in Review

127 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q2 2019, worth a combined $210M — down 46% from $392M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of DVAX and 22 opened new positions — a net loss of 8 holders — while 36 trimmed existing stakes and 37 added.

The largest buyer was Bain Capital Public Equity Management II, opening a new position worth an estimated $7.57M. The largest seller was State Street, cutting an estimated $13.7M.

  • 127 institutional investors held Dynavax Technologies (DVAX) as of Q2 2019, down from 137 in Q1 2019.
  • Funds reported $210M of Dynavax Technologies stock for Q2 2019, down 46% quarter-over-quarter.
  • 22 funds opened new Dynavax Technologies positions in Q2 2019 and 30 closed out, a net change of -8 holders.
  • The largest Dynavax Technologies buyer in Q2 2019 was Bain Capital Public Equity Management II, an estimated $7.57M added.
  • The largest Dynavax Technologies seller in Q2 2019 was State Street, an estimated $13.7M sold.

Based on aggregated 13F filings for Q2 2019.